170678 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Hydrolases (3) acting on peptide bonds (3.4); Plasminogen activators Urokinase
Novel Treatment of Diabetes and Kidney Disease by Inhibition of D2D3 a Proteolytic UPAR
#2PROTEIN BIOMARKERS OF INFLAMMATORY ACTIVITY IN MULTIPLE SCLEROSIS
#3DEVELOPMENT OF NOVEL UPAR SINGLE-DOMAIN ANTIBODY
#4SARS-COV-2 INFECTION RISK ASSESSMENT METHOD
#5METHODS OF DIAGNOSING TUBERCULOSIS AND DIFFERENTIATING BETWEEN ACTIVE AND LATENT TUBERCULOSIS
#6ASSESSMENT OF THE RISK OF COMPLICATION IN A PATIENT SUSPECTED OF HAVING AN INFECTION, HAVING A SOFA SCORE LOWER THAN TWO
#7Biomarkers useful in liver fibrosis diagnosis
#8Cardiotonic steroid antagonists and related methods
#9Antibodies that bind urokinase plasminogen activator
#10DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK
#11Biomarkers useful in liver fibrosis diagnosis
#12ASSAYS FOR CANCER PATIENT MONITORING BASED ON LEVELS OF ANALYTE COMPONENTS OF THE PLASMINOGEN ACTIVATOR SYSTEM IN BODY FLUID SAMPLES
#13PLASMINOGEN ACTIVATOR INHIBITOR AMELIORATION OF NEWBORN HYPOXIC ISCHEMIC BRAIN INJURY
#14BIOMARKERS USEFUL IN LIVER FIBROSIS DIAGNOSIS
#15PROCESS AND KIT FOR MEASURING THE CONDITION OF THE FIBRINOLITIC SYSTEM
#16Assays for Cancer Patient Monitoring Based on Levels of Analyte Components of the Plasminogen Activator System in Body Fluid Samples
#17METHOD OF IDENTIFYING CANCER BIOMARKERS AND CANCER PROGRESSION
#18METHOD OF IDENTIFYING CANCER BIOMARKERS AND CANCER PROGRESSION
#19DIAGNOSTIC BIOMARKERS FOR VASCULAR ANEURYSM
#20Method of identifying cancer biomarkers and cancer progression
#21Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
#22Companion diagnostic assays for endothelin receptor antagonists
#23Method for detecting the presence or risk of prostate cancer by detecting products of psa or klk2
#24Molecular-specific urokinase antibodies